Marc Zumberg, M.D.

Marc S Zumberg, M.D. - Research & Publications

(352) 265-8199

Request an Appointment

Publications

Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature
Transfusion
2019

A Patient-Centered Emergency Department Management Strategy for Sickle-Cell Disease Super-Utilizers

2017

Patient Satisfaction With Extended-Interval Warfarin Monitoring
Journal of Thrombosis and Thrombolysis
2016

Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency
BMJ Case Reports
2016

Steps to Diagnosis of a Case of Surreptitious Intake of One of the Newer Direct Oral Anticoagulants: a Case Report and Literature Review
Blood Coagulation & Fibrinolysis
2015

Reply: Clinical Experience With Prophylactic Fondaparinux in Critically Ill Patients With Moderate To Severe Renal Impairment Or Renal Failure Requiring Renal Replacement Therapy
Annals of Pharmacotherapy
2015

Preclinical Medical Student Hematology/Oncology Education Environment

2015

Feasibility of Extended-Interval Follow-Up for Patients Receiving Warfarin
Cardiovascular Therapeutics
2015

Myelodysplastic Syndrome and Associated Coagulopathy: a Case Report and Review
Blood Coagulation & Fibrinolysis
2014

Hemophilia C in a Patient Undergoing Cardiac Surgery: Perioperative Considerations
Seminars in cardiothoracic and vascular anesthesia
2014

Successful Implementation of a Packed Red Blood Cell and Fresh Frozen Plasma Transfusion Protocol in the Surgical Intensive Care Unit
Critical Care Medicine
2012

Intentional Low-Molecular-Weight Heparin Overdose: a Case Report and Review
Blood Coagulation & Fibrinolysis
2012

A Case Series of Atypical Presentations of Thrombotic Thrombocytopenic Purpura
Journal of Clinical Apheresis
2012

Labor and Delivery in a Patient With Hemophilia B
International Journal of Obstetric Anesthesia
2011

Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin By Continuous Intravenous Infusion
Annals of Pharmacotherapy
2011

Sirolimus-Induced Severe Hypertriglyceridemia in a Lung Transplant Recipient

2010

A massive pulmonary embolism treatment protocol: how trauma performance improvement affects outcome throughout the hospital system.
The American Surgeon
2010

A Massive Pulmonary Embolism Treatment Protocol: How Trauma Performance Improvement Affects Outcome Throughout the Hospital System
The American Surgeon
2010

Efficiency of a Weight-Based Low-Intensity Heparin Protocol for Patients Considered At High Risk for Bleeding
Critical Care Medicine
2009

Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists
American Journal of Hematology
2005

A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.

2002

Autoantibody formation in the alloimmunized red blood cell recipient: clinical and laboratory implications.
Archives of Internal Medicine
2001

Research Interests

  • Dr. Zumberg's intersts center around benign hematology and include ITP, HIT and Anemia.
  • Dr. Zumberg spends the majority of his time as a attending physician on the inpatient hematology consultation service at Shands Hospital. Dr. Zumberg also provides outpatient, new patient, and follow-up services at the outpatient Davis Cancer Center. He serves as the Medical Director of Therapeutic Apheresis for Lifesouth, the region's blood provider. He is also the Medical Director for the Shands-UF Outpatient Anticoagulation Clinic. He serves as Chairman for the Transfusion Committee at Shands Hospital. His research interests are in ITP, sickle cell disease, and other areas of benign hematology.